Laurus Labs receives USFDA tentative approval for Dolutegravir 5mg and 10mg in HIV/AIDS treatment
It will help in bringing a significant benefit in compliance of ARV medication in the paediatric HIV treatment
It will help in bringing a significant benefit in compliance of ARV medication in the paediatric HIV treatment
The strategic appointment is also critical to reinforcing Healthium’s market leadership, corporate governance and deep domain expertis
Clinic will offer Comprehensive Genetic Counselling and Testing Services to empower patients with personalized care
This approval reflects Biocon Biologics' compliance with the highest international regulatory standards
The appointment is effective from May 01, 2023 for five years
Cooperative agreement with U.S. Government to advance U.S. biopharma industry and ensure pandemic preparedness
The policymakers, doctors and, patient bodies discuss ways to implement thalassemia control programme nationally
Cipla has recently signed an agreement to make and market the diabetes therapy Galvus and its combination brands in India from 01 January 2026.
The funding will be used to expand the product line for remote patient monitoring and to scale the business across Asia and Africa
Subscribe To Our Newsletter & Stay Updated